Summary of the GLP-1 Receptor Agonist Market Market Definition The GLP-1 Receptor Agonist Market includes the development and sale of drugs that activate the glucagon-like peptide-1 (GLP-1) receptor, aimed at improving blood glucose control, reducing appetite, and supporting weight management in conditions such as type 2 diabetes and obesity
You may schedule a visit with a Teladoc Health care provider or your regular primary care provider, depending on your program During the visit, the care provider reviews your medical history and medications If you meet clinical criteria, your care provider may recommend a weight loss medication and, together, youll decide if its right for you If prescribed, your care provider will explain how to use the medication, expected results, possible side effects and how to monitor treatment After the prescription is submitted, additional steps may be required before the medication is filled
Increasing Prevalence of Type 2 Diabetes The cases of type 2 diabetes are rising across the world
What is metabolic syndrome